Side-by-side financials for CCCC and RVMD. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CCCC | RVMD |
|---|---|---|
| Market cap | - | $31.73 B |
| US-listed rank | - | #448 |
| Revenue (latest FY) | $35.95M | $0.00 |
| Net income (latest FY) | -$104.99M | -$1.13B |
| Net margin | -292.1% | - |
| SEC filings | 516 | 782 |
In their latest fiscal years, C4 Therapeutics, Inc. reported $35.95M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: C4 Therapeutics, Inc. and Revolution Medicines, Inc., or browse the full rankings.